Broadwood Capital

Latest statistics and disclosures from Broadwood Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are MNST, STAA, AXON, IWM, LCTX, and represent 99.36% of Broadwood Capital's stock portfolio.
  • Added to shares of these 3 stocks: LCTX (+$10M), STAA (+$8.8M), SER.
  • Started 1 new stock position in SER.
  • Reduced shares in these 2 stocks: MNST (-$11M), Agex Therapeutics.
  • Sold out of its position in Agex Therapeutics.
  • Broadwood Capital was a net buyer of stock by $7.4M.
  • Broadwood Capital has $1.3B in assets under management (AUM), dropping by 13.44%.
  • Central Index Key (CIK): 0001278387

Tip: Access up to 7 years of quarterly data

Positions held by Broadwood Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Broadwood Capital

Broadwood Capital holds 7 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Monster Beverage Corp (MNST) 36.9 $492M -2% 8.3M 59.28
 View chart
Staar Surgical Com Par $0.01 (STAA) 31.0 $412M +2% 11M 38.28
 View chart
Axon Enterprise (AXON) 17.9 $238M 760k 312.88
 View chart
Ishares Tr Russell 2000 Etf (IWM) 8.9 $119M 566k 210.30
 View chart
Lineage Cell Therapeutics In (LCTX) 4.6 $62M +19% 42M 1.48
 View chart
Oncocyte Corp Com New (OCX) 0.6 $7.4M 2.5M 2.93
 View chart
Serina Therapeutics Com Shs (SER) 0.1 $1.1M NEW 85k 13.46
 View chart

Past Filings by Broadwood Capital

SEC 13F filings are viewable for Broadwood Capital going back to 2010

View all past filings